A co-evolved peptide-GPCR system senses host entry to drive fungal infection.
Fungi don’t just randomly infect plants. They have a built-in peptide sensor that tells them when they’re inside a host. A new study on Ustilago maydis, the corn smut fungus, just mapped out this peptide-GPCR system in detail—and it’s a wild example of nature’s engineering.
Nat Commun
by Mendoza-Rojas G, Nakonz P, Lu M et al.
“A co-evolved peptide-GPCR system senses host entry to drive fungal infection. Mendoza-Rojas G(1), Nakonz P(1), Lu M(2), Kühne NM(3), Postma J(1), Shtakser N(1), Heinen M(1), Patel M(4), Arguello-Miranda O(4), Heimel K(3), Billerbeck S(2)(5), Altegoer F(6). Author information: (1)Heinrich-Heine University Düsseldorf, Institute of Microbiology, Cluster of Excellence on Plant Sciences, Düsseldorf, Germany. (2)University of Groningen, Faculty of Science and Engineering, Groningen, Netherlands. (3)Georg-August University Göttingen, Microbial Cell Biology, Göttingen, Germany. (4)NC State University, Plant and Microbial Biology, Raleigh, USA. (5)Imperial College London, Department of Bioengineering, London, UK. (6)Heinrich-Heine University Düsseldorf, Institute of Microbiology, Cluster of Excellence on Plant Sciences, Düsseldorf, Germany. altegoer@hhu.de. A successful infection requires pathogens to recognize the specific host environment in order to reprogram their physiology accordingly. One major way in which eukaryotic cells sense their surroundings is via G-Protein Coupled Receptors (GPCRs), which share a seven-transmembrane architecture and G-protein-mediated downstream signaling. While mammalian GPCRs are well-characterized and represent important drug targets, their fungal counterparts remain poorly understood. Here we uncover a GPCR-based mechanism that allows the corn pathogen Ustilago maydis to sense whether it has entered plant tissue. During infection, the fungus secretes the protein Pit2, which is cleaved by host apoplastic cysteine proteases, releasing a peptide ligand 'hidden' within the protein core. This ligand activates the fungal GPCR Gpe1, thus promoting fungal proliferation after initial host penetration. We elucidate the crystal structure of Pit2 and model the complex formed by Gpe1 and the Pit2-derived peptide. Structure-guided mutational analysis supports that disrupting this interaction reduces fungal virulence. The Gpe1/Pit2 system is conserved in related fungal species, with co-evolutionary signatures apparently preserving receptor-ligand specificity. Furthermore, this system shows mechanistic similarities to mammalian receptors, suggesting an evolutionary link between fungal and mammalian GPCRs. © 2026. The Author(s). Conflict of interest statement: Competing interests: The authors declare no competing interests.”
Here’s the play-by-play: When Ustilago maydis lands on a corn plant, it secretes a protein called Pit2. Host plant enzymes chop up Pit2, releasing a hidden peptide segment. This peptide then latches onto a fungal G-Protein Coupled Receptor (GPCR) named Gpe1. The signal: “You’re inside—go time.” The fungus ramps up its infection machinery, adapting to the host environment.
Why does this matter for peptide research? Most discussions about GPCRs focus on mammals, because they’re big pharmaceutical targets. But fungal GPCRs get less attention—even though they’re running similar molecular games. The researchers didn’t stop at discovering the mechanism. They cracked the crystal structure of Pit2, modeled the Gpe1/peptide complex, and showed that breaking this peptide-receptor handshake cuts down the fungus’s ability to infect. They even found that this system is conserved in related fungi, with protein tweaks preserving the peptide-GPCR match-up across species.
Key takeaway: Peptide-GPCR systems are ancient, adaptable, and key to how organisms sense and respond to their environments. If you study signaling peptides, this opens up a new angle. Fungal research isn’t just about plant pathogens—it’s a playground for understanding peptide evolution, specificity, and mechanism.
Check the peptide research index for more context on signaling peptides, or explore the vendor directory if you’re sourcing peptides for your own work. This field keeps delivering surprises—don’t sleep on the fungal side of peptide signaling.
Related Reading
Periocular surgery risk after glucagon-like peptide-1 receptor agonist therapy for type 2 diabetes.
News · OMICSOral Versus Injectable Incretin-Based Anti-Obesity Therapies: An Integrated Computational and Evidence-Based Comparison of Orforglipron, Semaglutide, and Tirzepatide.
News · Cell Rep MedGut-derived glucagon-like peptides attenuate T cell-induced intestinal injury.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.